1. Yang, Binyao, Zhang, Lisha, Cao, Yi, Huang, Yunchao, Lu, Jiachun. 2017. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression. In Molecular cancer, 16, 154. doi:10.1186/s12943-017-0722-8. https://pubmed.ncbi.nlm.nih.gov/28946875/
2. Shi, Yuye, Xu, Xiaohu, He, Zhengmei, Wang, Chunling, Yu, Liang. 2023. AKAP12 and IGFBP4 Are Prognostic Factors for Chronic Lymphocytic Leukemia. In Acta haematologica, 146, 474-481. doi:10.1159/000530618. https://pubmed.ncbi.nlm.nih.gov/37605556/
3. Peng, Zhanli, Kan, Qinghui, Wang, Kangjie, Wu, Ridong, Yao, Chen. 2024. Deciphering smooth muscle cell heterogeneity in atherosclerotic plaques and constructing model: a multi-omics approach with focus on KLF15/IGFBP4 axis. In BMC genomics, 25, 490. doi:10.1186/s12864-024-10379-y. https://pubmed.ncbi.nlm.nih.gov/38760675/
4. Tao, Liye, Wang, Yali, Shen, Zefeng, Xu, Junjie, Liang, Xiao. 2023. Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinoma. In Hepatology international, 18, 91-107. doi:10.1007/s12072-023-10552-7. https://pubmed.ncbi.nlm.nih.gov/37349627/
5. Xi, Yue, Liu, Jianlin, Shen, Gufeng. 2022. Low expression of IGFBP4 and TAGLN accelerate the poor overall survival of osteosarcoma. In Scientific reports, 12, 9298. doi:10.1038/s41598-022-13163-8. https://pubmed.ncbi.nlm.nih.gov/35665757/
6. Mindikoglu, Ayse L, Abdulsada, Mustafa M, Jain, Antrix, Opekun, Antone R, Jung, Sung Yun. 2020. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. In Scientific reports, 10, 18341. doi:10.1038/s41598-020-73767-w. https://pubmed.ncbi.nlm.nih.gov/33110154/
7. Shen, Quiang, Singh, Pomila. . Identification of a novel SP3 binding site in the promoter of human IGFBP4 gene: role of SP3 and AP-1 in regulating promoter activity in CaCo2 cells. In Oncogene, 23, 2454-64. doi:. https://pubmed.ncbi.nlm.nih.gov/14767471/
智鼠故事 
